Clinical Trials on Benzodiazepine (BZD) and Related Drugs in New Zealand

Total 6248 results

New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Sequenced Behavioral and Medication Intervention for Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Glutamatergic Modulation of Cocaine-related Deficits

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (Vyvance)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Aripiprazole on Cocaine Craving and Self-Administration

Cocaine Abuse

United States
New York State Psychiatric Institute
Novel Cocaine Pharmacotherapies

Terminated

Effects of Vigabatrin on Cocaine Self-Administration

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Progesterone Treatment for Cocaine-dependent Women: A Pilot Study (PROG)

Cocaine Dependence

United States
Hurd,Yasmin, Ph.D.
Jazz Pharmaceuticals

Recruiting

Neuroimaging and CBD for Opiod Use Disorder

Substance-Related Disorders | Opioid-Related Disorders | Opioid Use Disorder | Heroin Abuse

United States
NYU Langone Health

Completed

A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment (CATCH)

Opioid Dependence | Opioid Abuse

United States
New York State Psychiatric Institute

Completed

The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving (FRAME)

Alcoholism

United States
We The Village, Inc.
National Institute on Drug Abuse (NIDA); Public Health Management Corporation

Active, not recruiting

Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones

Substance-Related Disorders | Family Health | Community Reinforcement And Family Training

United States
University of Utah
Rutgers University

Not yet recruiting

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

Substance-Related Disorders | Mental Disorders | Chemically-Induced Disorders | Pain | Neurologic Manifestations | Chronic Pain | Opioid-Related Disorders | Narcotic-Related Disorders | Prescription Opioid Misuse

United States
Yale University
University of Pennsylvania

Recruiting

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

Opioid Use Disorder

United States
Montefiore Medical Center

Recruiting

Low-dose Buprenorphine Initiation for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Terminated

Neurofeedback in Individuals With Substance Use Disorders

Opioid-Related Disorders

United States
Pear Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Kaiser Foundation Research Institute; Whitman-Walker Institute, Inc... and other collaborators

Completed

Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence

Opioid Use Disorder

United States
New York State Psychiatric Institute

Completed

An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder

Opioid-use Disorder

United States
Children's Oncology Group
National Cancer Institute (NCI); Children's Cancer Group

Completed

Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease

Lymphoma | Cardiac Toxicity

United States, Australia, Canada
Icahn School of Medicine at Mount Sinai

Active, not recruiting

Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery

Lumbar Spine Pathology | Elective Spine Surgery

United States
NYU Langone Health
Wright State University

Completed

Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments

Opioid Dependence

United States
Albert Einstein College of Medicine
Montefiore Medical Center; Fordham University

Completed

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

HIV Infections | HIV | Cognition | Opioid-related Disorders | Buprenorphine

United States
NYU Langone Health
Alkermes, Inc.; New York City Department of Health and Mental Hygiene

Completed

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Opiate Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Modeling Impaired Judgement in Cocaine Abusers - 6

Substance-Related Disorders | Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence (TACT)

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence (COST)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Columbia University

Completed

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) (COST)

Cocaine Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Modafinil for Smoked Cocaine Self-Administration

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Therapeutic Cocaine Vaccine: Human Laboratory Study

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence (PET-CRA)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Early Phase II Trials for Cocaine Medication Development - 1

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Pergolide Treatment for Substance Abusers - 4

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Substance-Related Disorders | Cocaine-Related Disorders

United States
NYU Langone Health
Alkermes, Inc.

Completed

Extended-release Naltrexone for Alcohol Dependence in Primary Care

Alcohol Dependence

United States
Montefiore Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Group Medical Visits in Primary Care (G-BMT)

Opioid-Related Disorders

United States
All India Institute of Medical Sciences, New Delhi

Completed

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Tuberculosis | Drug Induced Hepatotoxicity

India
Yale University
National Institute on Drug Abuse (NIDA)

Completed

The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders

Cocaine-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Mazindol for Cocaine Abuse - 2

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
US Department of Veterans Affairs

Completed

Alterations in Serotonergic Functions in Cocaine Addicts - 1

Cocaine-Related Disorders

United States
Maimonides Medical Center

Terminated

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Opioid Use Disorder

United States
Dartmouth-Hitchcock Medical Center
National Center for Complementary and Integrative Health (NCCIH); Trustees...

Completed

Mindful Moms in Recovery (MMORE)

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Disulfiram for Cocaine-Alcohol Abuse - 3

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Glutaminergic Agents for Cocaine Abuse - 5

Cocaine-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Pemoline for Cocaine Abuse - 7

Cocaine-Related Disorders

United States
Rowan University
The Cooper Health System

Recruiting

Increasing MAT Engagement With Financial Incentives

Opioid-use Disorder

United States
Rutgers University

Completed

Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder

Opioid-use Disorder

United States
CBT4CBT, LLC

Completed

CBT4CBT for Office Based Buprenorphine

Opioid-use Disorder

United States
New York State Psychiatric Institute

Terminated

Evaluation of Doxazosin to Alter the Abuse of Oxycodone

Opioid-use Disorder

United States

Clinical Trials on Benzodiazepine (BZD) and Related Drugs in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations